These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35413566)

  • 1. Generation of two iPSC lines from hypertrophic cardiomyopathy patients carrying MYBPC3 and PRKAG2 variants.
    Manhas A; Jahng JWS; Vera CD; Shenoy SP; Knowles JW; Wu JC
    Stem Cell Res; 2022 May; 61():102774. PubMed ID: 35413566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy.
    Liu L; Shenoy SP; Jahng JWS; Liu Y; Knowles JW; Zhuge Y; Wu JC
    Stem Cell Res; 2021 May; 53():102279. PubMed ID: 33743363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/c.3764C>A mutation.
    Sun Y; Zhou J; Wang H; Wang H; Chen X; Gong T; Liang P; Jiang C
    Stem Cell Res; 2022 Oct; 64():102898. PubMed ID: 36041398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heterozygous MYBPC3 (c. 772+1G > A) mutant human induced pluripotent stem cell line (ZZUNEUi025-A) generated from a male patient with hypertrophic cardiomyopathy.
    Zhao X; Cao J; Li X; Liu M; Liu Y; Dong J; Zhao X
    Stem Cell Res; 2022 Apr; 60():102722. PubMed ID: 35257994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integration-free iPSC line ZZUNEUi028-A derived from a patient with hypertrophic cardiomyopathy carrying a heterozygous mutation (c. 1504 C > T) in MYBPC3 gene.
    Cheng D; Zhang S; Li X; Wang L; Dong J; Sang H
    Stem Cell Res; 2022 Aug; 63():102848. PubMed ID: 35772297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation.
    Mori H; Xu D; Shimoda Y; Yuan Z; Murakata Y; Xi B; Sato K; Yamamoto M; Tajiri K; Ishizu T; Ieda M; Murakoshi N
    Sci Rep; 2024 Jul; 14(1):15422. PubMed ID: 38965264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying MYBPC3 nonsense mutations.
    Ribeiro M; Jager J; Furtado M; Carvalho T; Cabral JMS; Brito D; Carmo-Fonseca M; Martins S; da Rocha ST
    Stem Cell Res; 2024 Apr; 76():103362. PubMed ID: 38417376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations.
    Cao X; Jahng JWS; Lee C; Zha Y; Wheeler MT; Sallam K; Wu JC
    Stem Cell Res; 2021 Aug; 55():102455. PubMed ID: 34352619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy.
    Warnecke N; Ulmer BM; Laufer SD; Shibamiya A; Krämer E; Neuber C; Hanke S; Behrens C; Loos M; Münch J; Kühnisch J; Klaassen S; Eschenhagen T; Patten-Hamel M; Carrier L; Mearini G
    Stem Cell Res; 2021 Aug; 55():102489. PubMed ID: 34375846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3.
    Dementyeva EV; Pavlova SV; Chernyavsky AM; Zakian SM
    Stem Cell Res; 2021 May; 53():102344. PubMed ID: 33892289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying the MYBPC3 missense c.1484G>A mutation.
    Ribeiro M; Martins S; Carvalho T; Furtado M; Sampaio Cabral J; Brito D; Carmo-Fonseca M; da Rocha ST
    Stem Cell Res; 2024 Feb; 74():103282. PubMed ID: 38104429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational investigation of electrophysiology in hypertrophic cardiomyopathy.
    Flenner F; Jungen C; Küpker N; Ibel A; Kruse M; Koivumäki JT; Rinas A; Zech ATL; Rhoden A; Wijnker PJM; Lemoine MD; Steenpass A; Girdauskas E; Eschenhagen T; Meyer C; van der Velden J; Patten-Hamel M; Christ T; Carrier L
    J Mol Cell Cardiol; 2021 Aug; 157():77-89. PubMed ID: 33957110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An induced pluripotent stem cell line (EHTJUi003-A) generated from a neonate with c.1377delC mutation in the gene MYBPC3 causing hypertrophic cardiomyopathy.
    Jia WW; Lu JZ; Zhang L; Cao HX; Qi YY; Zhu HY; Bai ZH; Zhang SM; Qiao ZB; Bao Y; Liu ZM
    Stem Cell Res; 2021 May; 53():102328. PubMed ID: 34087980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An induced pluripotent stem cell line (YCMi006-A) generated from a patient with hypertrophic cardiomyopathy who carries the ACTA1 mutation p.Ile343Met.
    Kim H; Kim HJ; Oh J; Lee ST; Won D; Choi HK; Choi JR; Kim S; Kim HP; Kim SJ; Park SW; Kang SM; Lee SH
    Stem Cell Res; 2022 Aug; 63():102874. PubMed ID: 35917599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.
    Seeger T; Shrestha R; Lam CK; Chen C; McKeithan WL; Lau E; Wnorowski A; McMullen G; Greenhaw M; Lee J; Oikonomopoulos A; Lee S; Yang H; Mercola M; Wheeler M; Ashley EA; Yang F; Karakikes I; Wu JC
    Circulation; 2019 Feb; 139(6):799-811. PubMed ID: 30586709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human
    Pioner JM; Vitale G; Steczina S; Langione M; Margara F; Santini L; Giardini F; Lazzeri E; Piroddi N; Scellini B; Palandri C; Schuldt M; Spinelli V; Girolami F; Mazzarotto F; van der Velden J; Cerbai E; Tesi C; Olivotto I; Bueno-Orovio A; Sacconi L; Coppini R; Ferrantini C; Regnier M; Poggesi C
    Circ Res; 2023 Mar; 132(5):628-644. PubMed ID: 36744470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation.
    Ribeiro M; Jager J; Furtado M; Carvalho T; Cabral JMS; Brito D; Carmo-Fonseca M; Martins S; da Rocha ST
    Hum Cell; 2024 Jul; 37(4):1205-1214. PubMed ID: 38762696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of human induced pluripotent stem cell lines derived from four patients with a pathogenic ALPK3 variant associated with adult-onset hypertrophic cardiomyopathy (HCM).
    Cheawsamoot C; Ramchandani R; Ameen M; Arthur Ataam J; Khongphatthanayothin A; Shotelersuk V; Karakikes I
    Stem Cell Res; 2023 Dec; 73():103233. PubMed ID: 37944352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation.
    Zhou J; Sun Y; Wang H; Wang H; Guo F; Chen X; Gong T; Jiang C; Liang P
    Stem Cell Res; 2022 Oct; 64():102883. PubMed ID: 35944310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.